|
Originally published In Press as doi:10.1074/jbc.M512178200 on January 5, 2006
J. Biol. Chem., Vol. 281, Issue 13, 8686-8696, March 31, 2006
Antianoikis Effect of Nuclear Factor- B through Up-regulated Expression of Osteoprotegerin, BCL-2, and IAP-1*
Murat Toruner ,
Martin Fernandez-Zapico ,
Jing Jing Sha ,
Linh Pham ,
Raul Urrutia , and
Laurence J. Egan ¶1
From the
Gastroenterology Research Unit and Molecular Medicine Program, Mayo Clinic, Rochester, Minnesota 55905 and the ¶Department of Pharmacology and Therapeutics, National University of Ireland, Galway, Ireland
Epithelial cells undergo a form of apoptosis termed anoikis when they lose extracellular attachments. We evaluated the role of transcription factor NF- B in the regulation of anoikis susceptibility of intestinal epithelial cells. Culture of rat intestinal epithelial cells in suspension induced NF- B activation, which blocked the anoikis of those cells, as assessed by internucleosomal DNA fragmentation and caspase-3 cleavage. Activation of NF- B after the loss of extracellular attachments required focal adhesion kinase tyrosine 397 phosphorylation. This triggered a signaling cascade through phosphatidylinositol 3-kinase and AKT, to induce DNA binding of the RelA/p65 NF- B polypeptide. NF- B activated in this manner induced the up-regulated expression of a distinct program of genes that included osteoprotegerin, BCL-2, and IAP-1 (inhibitor of apoptosis protein-1). Chromatin immunoprecipitation experiments revealed that NF- B directly regulated the promoters of these 3 genes. Knock-down of the expression of osteoprotegerin, BCL-2, or inhibitor of apoptosis protein-1 by RNA interference showed that these factors inhibit anoikis, and genetic reconstitution of their expression alone or in combination restored normal levels of anoikis to NF- B-inactive intestinal epithelial cells. Together, these findings have identified the molecular components of a previously unrecognized antianoikis pathway in intestinal epithelial cells.
Received for publication, November 14, 2005
, and in revised form, January 4, 2006.
* This work was supported by National Institutes of Health Grant DK60792 and a Crohn's and Colitis Foundation of America award (both to L. J. E.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
1 To whom correspondence should be addressed: Dept. of Pharmacology and Therapeutics, Clinical Science Institute, University College Hospital, Galway, Ireland. Tel.: 353-91-495355; Fax: 353-91-495572.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
N. K. Decker, S. S. Abdelmoneim, U. Yaqoob, H. Hendrickson, J. Hormes, M. Bentley, H. Pitot, R. Urrutia, G. J. Gores, and V. H. Shah
Nitric Oxide Regulates Tumor Cell Cross-Talk with Stromal Cells in the Tumor Microenvironment of the Liver
Am. J. Pathol.,
October 1, 2008;
173(4):
1002 - 1012.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Secchiero, F. Corallini, E. Rimondi, C. Chiaruttini, M. G. di Iasio, A. Rustighi, G. Del Sal, and G. Zauli
Activation of the p53 pathway down-regulates the osteoprotegerin expression and release by vascular endothelial cells
Blood,
February 1, 2008;
111(3):
1287 - 1294.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2006 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|